ProAir® HFA was approved by the FDA in October 2004 for treatment or prevention of bronchospasm with reversible obstructive airway disease in adults and children 12 years of age and older. In ...
The U.S. Food and Drug Administration has approved the first generic rescue inhaler to treat asthma. The albuterol sulfate inhaler can be used to treat or prevent bronchospasms in patients four years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback